155 related articles for article (PubMed ID: 19047898)
1. Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma.
Downs-Kelly E; Nayeemuddin KM; Albarracin C; Wu Y; Hunt KK; Gilcrease MZ
Am J Surg Pathol; 2009 Apr; 33(4):534-41. PubMed ID: 19047898
[TBL] [Abstract][Full Text] [Related]
2. [Matrix-producing metaplastic carcinoma: a clinicopathologic and prognostic analysis of 16 cases with review of literature].
Zhang Z; Bu H; Huang H; Zhang J; Lang Z; Zhao T; Wang J; Liao D; Wei B
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):528-32. PubMed ID: 25346122
[TBL] [Abstract][Full Text] [Related]
3. Metaplastic breast carcinoma with extensive osseous differentiation: a report of two cases and review of the literature.
Lang R; Fan Y; Fu X; Fu L
Tumori; 2011; 97(4):e1-5. PubMed ID: 21989447
[TBL] [Abstract][Full Text] [Related]
4. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
[TBL] [Abstract][Full Text] [Related]
5. Matrix-producing carcinoma of the breast in the Chinese population: a clinicopathological study of 13 cases.
Shui R; Bi R; Cheng Y; Lu H; Wang J; Yang W
Pathol Int; 2011 Jul; 61(7):415-22. PubMed ID: 21707845
[TBL] [Abstract][Full Text] [Related]
6. Matrix-producing metaplastic breast carcinoma - a rare tumor with heterologous elements.
Shruti S; Siraj F
Ger Med Sci; 2017; 15():Doc17. PubMed ID: 29255401
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Matrix-Producing Carcinoma of the Breast].
Inoue Y; Joden F; Yabuki K; Sato N; Minagawa N; Katsuki T; Sato N; Nagata T; Shibao K; Matsuyama A; Aoki T; Hirata K
J UOEH; 2017; 39(2):167-173. PubMed ID: 28626128
[TBL] [Abstract][Full Text] [Related]
8. Matrix-producing mammary carcinoma: a rare breast tumor.
Mardi K; Sharma J
Indian J Pathol Microbiol; 2008; 51(2):263-4. PubMed ID: 18603703
[TBL] [Abstract][Full Text] [Related]
9. Invasive ductal carcinoma of the breast with a large central acellular zone associated with matrix-producing carcinoma.
Hama Y; Tsuda H; Sato K; Hiraide H; Mochizuki H; Kusano S
Tumori; 2004; 90(5):498-500. PubMed ID: 15656336
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival.
Nguyen CV; Falcón-Escobedo R; Hunt KK; Nayeemuddin KM; Lester TR; Harrell RK; Bassett RL; Gilcrease MZ
Am J Surg Pathol; 2010 Apr; 34(4):486-93. PubMed ID: 20154588
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
[TBL] [Abstract][Full Text] [Related]
12. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.
Laird J; Lok B; Siu C; Cahlon O; Khan AJ; McCormick B; Powell SN; Cody H; Wen HY; Ho A; Braunstein LZ
Ann Surg Oncol; 2018 Jan; 25(1):154-163. PubMed ID: 29094250
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
[No Abstract] [Full Text] [Related]
14. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
15. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status.
Blackwell K; Haroon Z; Broadwater G; Berry D; Harris L; Iglehart JD; Dewhirst M; Greenberg C
J Clin Oncol; 2000 Feb; 18(3):600-8. PubMed ID: 10653875
[TBL] [Abstract][Full Text] [Related]
16. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
Krings G; Chen YY
Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic carcinoma of the breast with osteocartilaginous heterologous elements.
Chhieng C; Cranor M; Lesser ME; Rosen PP
Am J Surg Pathol; 1998 Feb; 22(2):188-94. PubMed ID: 9500219
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment.
Solin LJ; Yeh IT; Kurtz J; Fourquet A; Recht A; Kuske R; McCormick B; Cross MA; Schultz DJ; Amalric R
Cancer; 1993 Apr; 71(8):2532-42. PubMed ID: 8384070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
